Market News AIOpen the app

Adagene has started its first Phase 1 study by giving the new drug ADG138 to its first patient.

TrialRead the original at globenewswire.com
Good for ADAG

Adagene has begun human testing of ADG138, a positive step for its cancer-drug pipeline. The study has not shown whether the treatment works or avoids harm.

ADAG · Adagene

AI read · Good for ADAG

The AI's read

This moves ADG138 into human testing and adds progress to Adagene's cancer-drug pipeline. The study has not shown whether the treatment works or avoids harm, so its promise remains unproven.

Get alerts for ADAG

Follow Adagene (ADAG) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ADAG
Free on the App Store and Google Play, or on the web.